EDAP - EDAP TMS S.A.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

EDAP TMS S.A.

Parc d’Activites la Poudrette-Lamartine
4/6, rue du Dauphiné
Vaulx-en-Velin 69120
France
33 4 72 15 31 50
http://www.edap-tms.com

SectorHealthcare
IndustryMedical Appliances & Equipment
Full Time Employees197

Key Executives

NameTitlePayExercisedAge
Mr. Marc OczachowskiCEO & DirectorN/AN/A47
Mr. Franois DietschChief Financial OfficerN/AN/A41
Mrs. Blandine ConfortInvestor Relations Officer and Sec.N/AN/AN/A
Ms. Judith JohannsenSales Director for Germany Austria & Switzerland and Gen. Mang. of Edap GmbhN/AN/AN/A
Mr. John Cameron RewcastleVP of Strategic Devel.N/AN/A43
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

Corporate Governance

EDAP TMS S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.